Rating Change
Guggenheim analysts reiterated a Buy rating on Illumina, Inc. (NASDAQ:ILMN) on June 29, 2026.
reiterateNASDAQ:ILMN
Guggenheim Reiterates Buy Rating on Illumina, Inc. (ILMN)
Rating Change Guggenheim analysts reiterated a Buy rating on Illumina, Inc. (NASDAQ:ILMN) on June 29, 2026. Market Context Illumina, Inc.
Market Context
Illumina, Inc. operates in the Healthcare sector. The stock currently trades at $181.10 with a market capitalization of $20.8B. The stock has gained 94.2% over the past 52 weeks.
Analyst coverage from Guggenheim provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Illumina, Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Illumina, Inc.
Among the 10 most recent ratings: 4 Buy, 3 Hold, 3 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jun 29, 2026 | Guggenheim | Buy | N/A |
| Jun 26, 2026 | Bernstein | Market Perform | N/A |
| Jun 24, 2026 | Barclays | Underweight | N/A |
| Jun 10, 2026 | JP Morgan | Overweight | N/A |
| Jun 01, 2026 | Guggenheim | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View ILMN Stock Page
Frequently Asked Questions
What does a Buy rating mean for ILMN?
A Buy rating from Guggenheim reflects the analyst's outlook on Illumina, Inc. (NASDAQ:ILMN). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the ILMN forecast page.